Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Healthcare Professional Education and Support Programmes

Sponsored by

Back to Results


Highly Commended

Academy for Science and Continuing Medical Education in Diabetes (ASCEND)

by Novo Nordisk [unrestricted grant provider] with support from International Medical Press, a Nucleus Global agency


Summary of work

ASCEND is an independent, global, multichannel educational programme to support PCPs and their patients with type 2 diabetes in achieving glycaemic management goals.

An International Steering Committee and ~120 National Educators supported curriculum development with the Behaviour Change Unit at UCL and a clinical psychologist from UCH, London. The programme was rolled out in Algeria, China, India, Indonesia, Malaysia, Mexico, Pakistan, Peru and Saudi Arabia, in partnership with national medical societies and accrediting organisations. The blended curriculum consisted of 1.5-day live events (including small group working and case study-based learning) and ten hours of eLearning.

2,450 PCPs have participated at 38 events. At the live events, gains in knowledge/confidence averaged 20% and almost 20,000 CME credits were awarded. Over 32,000 hours of eLearning were completed at www.ascend-diabetes.com with knowledge/confidence gains of 25%. Learners gave very positive feedback on clinical relevance, lack of bias and effective learning formats.

Learners committed to change their behaviour, which was evaluated by follow-up after 12–18 months. Most respondents had changed their clinical practice with significant improvements in their patients’ glycaemic control.

ASCEND is a CME-accredited programme supported by an educational grant from Novo Nordisk, who has no input into content or faculty selection.

Judges' comments

This was a solid programme of real scale. The lessons learnt were strong and specific and the values were robust and the statements were positive. It was clear what Novo Nordisk and IMP planned to do and the objectives were clear and measurable with strong evidence of health outcomes. It was impressive that the participants were followed up for 12-18 months and was good to see the lessons learnt on what didn’t work so well.


Winner

Angels Initiative - by Boehringer Ingelheim International GmbH


Highly commended

CLEAR HORIZONS: A New Era of Psoriasis Care - by AbbVie with support from Lucid Group


Highly commended

Academy for Science and Continuing Medical Education in Diabetes (ASCEND) - by Novo Nordisk [unrestricted grant provider] with support from International Medical Press, a Nucleus Global agency


Finalists

INSPIRE: Improving Outcomes in Paediatric Cardiology - by AbbVie with support from Lucid Group

4 Sites: Navigating the Course Ahead - by AbbVie with support from Sciterion

Advanced Communication Training for Heart Failure Nurses - by Novartis with support from Aurora


PMEA Awards 2020

Key dates

Entry deadline 27 August 2020
Extended entry deadline 3 September 2020*
*additional fee applies
Judging Day 1 October 2020
Company of the Year Interviews 22 October 2020
PMEA Event 25 November 2020